Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: The novel oncogenic factor TET3 combines with AHR to promote thyroid cancer lymphangiogenesis via the HIF-1α/VEGF signaling pathway

Fig. 3

TET3 and AHR promote the growth of THCA cells by inducing G2/M phase arrest and restraining apoptosis in vitro. A.B. RT-PCR of AHR expression in BTH101 and BCPAP cells with the transient transfection of AHR siRNA (siRNA1, siRNA2 and siRNA3). CD TET3 and AHR accelerated the proliferation of THCA cells in colony formation assay. EFGHIJ The TET3 and AHR activation induced THCA cells G2/M phase arrest. KL. TET3 and AHR activation increased the percentage of THCA cells in the G2/M phase

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us